BioLife Solutions Inc.
BLFSBioLife Solutions Inc. (BLFS) is a provider of biopreservation tools and systems for the long-term storage of cells, tissues, and organs. The company develops and markets advanced cryopreservation media, controlled-rate thawing systems, and other bioprocessing products primarily serving the biopharmaceutical, cell and gene therapy, and regenerative medicine industries. BioLife Solutions aims to improve the safety and efficacy of cell-based therapies through its innovative preservation technology.
Company News
The global cell therapy packaging market is projected to grow from $419.57 million in 2025 to $1.27 billion by 2034, driven by increasing demand for cell and gene therapies, technological advancements, and specialized packaging solutions.
BioLife Solutions announced its management will participate in multiple investor conferences in November and December 2025, including events in Napa Valley, Nashville, London, and virtual conferences focused on small-cap and healthcare sectors.
SA seasonality charts identified 4 Strong Buy stocks with high July win rates and 10Y average returns. Click here for 4 top July stocks.
BioLife's (BLFS) latest product, CryoCase, is compatible with various downstream processing systems, including its own Signata CT-5.
The company saw revenue decline, year over year, in the second quarter.
